These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38063059)

  • 1. The use of electroporation to deliver DNA-based vaccines.
    Kisakov DN; Belyakov IM; Kisakova LA; Yakovlev VA; Tigeeva EV; Karpenko LI
    Expert Rev Vaccines; 2024; 23(1):102-123. PubMed ID: 38063059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electroporation mediated DNA vaccination directly to a mucosal surface results in improved immune responses.
    Kichaev G; Mendoza JM; Amante D; Smith TR; McCoy JR; Sardesai NY; Broderick KE
    Hum Vaccin Immunother; 2013 Oct; 9(10):2041-8. PubMed ID: 23954979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of electroporation-enhanced intradermal delivery of DNA vaccine using a minimally invasive surface device.
    Lin F; Shen X; Kichaev G; Mendoza JM; Yang M; Armendi P; Yan J; Kobinger GP; Bello A; Khan AS; Broderick KE; Sardesai NY
    Hum Gene Ther Methods; 2012 Jun; 23(3):157-68. PubMed ID: 22794496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo electroporation of minicircle DNA as a novel method of vaccine delivery to enhance HIV-1-specific immune responses.
    Wang Q; Jiang W; Chen Y; Liu P; Sheng C; Chen S; Zhang H; Pan C; Gao S; Huang W
    J Virol; 2014 Feb; 88(4):1924-34. PubMed ID: 24284319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electroporation of a nanoparticle-associated DNA vaccine induces higher inflammation and immunity compared to its delivery with microneedle patches in pigs.
    Bernelin-Cottet C; Urien C; McCaffrey J; Collins D; Donadei A; McDaid D; Jakob V; Barnier-Quer C; Collin N; Bouguyon E; Bordet E; Barc C; Boulesteix O; Leplat JJ; Blanc F; Contreras V; Bertho N; Moore AC; Schwartz-Cornil I
    J Control Release; 2019 Aug; 308():14-28. PubMed ID: 31265882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel prototype device for electroporation-enhanced DNA vaccine delivery simultaneously to both skin and muscle.
    Lin F; Shen X; McCoy JR; Mendoza JM; Yan J; Kemmerrer SV; Khan AS; Weiner DB; Broderick KE; Sardesai NY
    Vaccine; 2011 Sep; 29(39):6771-80. PubMed ID: 21199706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Phase 1 clinical trial of a DNA vaccine for Venezuelan equine encephalitis delivered by intramuscular or intradermal electroporation.
    Hannaman D; Dupuy LC; Ellefsen B; Schmaljohn CS
    Vaccine; 2016 Jun; 34(31):3607-12. PubMed ID: 27206386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electroporation enhances protective immune response of a DNA vaccine against Japanese encephalitis in mice and pigs.
    Sheng Z; Gao N; Cui X; Fan D; Chen H; Wu N; Wei J; An J
    Vaccine; 2016 Nov; 34(47):5751-5757. PubMed ID: 27743649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods.
    Wang S; Zhang C; Zhang L; Li J; Huang Z; Lu S
    Vaccine; 2008 Apr; 26(17):2100-10. PubMed ID: 18378365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of In Vivo Electroporation Conditions and Delivery of DNA Vaccine Encoding SARS-CoV-2 RBD Using the Determined Protocol.
    Kisakov DN; Kisakova LA; Borgoyakova MB; Starostina EV; Taranov OS; Ivleva EK; Pyankov OV; Zaykovskaya AV; Shcherbakov DN; Rudometov AP; Rudometova NB; Volkova NV; Gureev VN; Ilyichev AA; Karpenko LI
    Pharmaceutics; 2022 Oct; 14(11):. PubMed ID: 36365078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electroporation enhances immunogenicity of a DNA vaccine expressing woodchuck hepatitis virus surface antigen in woodchucks.
    Liu KH; Ascenzi MA; Bellezza CA; Bezuidenhout AJ; Cote PJ; Gonzalez-Aseguinolaza G; Hannaman D; Luxembourg A; Evans CF; Tennant BC; Menne S
    J Virol; 2011 May; 85(10):4853-62. PubMed ID: 21389124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipose tissue: a new target for electroporation-enhanced DNA vaccines.
    Fisher PD; Brambila CJ; McCoy JR; Kiosses WB; Mendoza JM; Oh J; Yung BS; Schultheis K; Smith TRF; Broderick KE
    Gene Ther; 2017 Dec; 24(12):757-767. PubMed ID: 29106403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electroporation-enhanced delivery of nucleic acid vaccines.
    Broderick KE; Humeau LM
    Expert Rev Vaccines; 2015 Feb; 14(2):195-204. PubMed ID: 25487734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of needle-free jet injection with advanced electroporation delivery enhances the magnitude, kinetics, and persistence of engineered DNA vaccine induced immune responses.
    Jiang J; Ramos SJ; Bangalore P; Fisher P; Germar K; Lee BK; Williamson D; Kemme A; Schade E; McCoy J; Muthumani K; Weiner DB; Humeau LM; Broderick KE
    Vaccine; 2019 Jun; 37(29):3832-3839. PubMed ID: 31174938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of the immunogenicity of an alphavirus replicon-based DNA vaccine against classical swine fever by electroporation and coinjection with a plasmid expressing porcine interleukin 2.
    Tian DY; Sun Y; Wai SF; Lee FK; Meng QL; Suen KM; Wang N; Han W; Li S; Li YF; Li D; Ling LJ; Liao YJ; Qiu HJ
    Vaccine; 2012 May; 30(24):3587-94. PubMed ID: 22469861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electroporation delivery of DNA vaccines: prospects for success.
    Sardesai NY; Weiner DB
    Curr Opin Immunol; 2011 Jun; 23(3):421-9. PubMed ID: 21530212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers.
    Vasan S; Hurley A; Schlesinger SJ; Hannaman D; Gardiner DF; Dugin DP; Boente-Carrera M; Vittorino R; Caskey M; Andersen J; Huang Y; Cox JH; Tarragona-Fiol T; Gill DK; Cheeseman H; Clark L; Dally L; Smith C; Schmidt C; Park HH; Kopycinski JT; Gilmour J; Fast P; Bernard R; Ho DD
    PLoS One; 2011; 6(5):e19252. PubMed ID: 21603651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markedly enhanced immunogenicity of a Pfs25 DNA-based malaria transmission-blocking vaccine by in vivo electroporation.
    LeBlanc R; Vasquez Y; Hannaman D; Kumar N
    Vaccine; 2008 Jan; 26(2):185-92. PubMed ID: 18054817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo electroporation in DNA-VLP prime-boost preferentially enhances HIV-1 envelope-specific IgG2a, neutralizing antibody and CD8 T cell responses.
    Huang X; Zhu Q; Huang X; Yang L; Song Y; Zhu P; Zhou P
    Vaccine; 2017 Apr; 35(16):2042-2051. PubMed ID: 28318765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo electroporation enhances vaccine-mediated therapeutic control of human papilloma virus-associated tumors by the activation of multifunctional and effector memory CD8
    Sales NS; Silva JR; Aps LRMM; Silva MO; Porchia BFMM; Ferreira LCS; Diniz MO
    Vaccine; 2017 Dec; 35(52):7240-7249. PubMed ID: 29174677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.